Research & KnowledgeEvent: September 1, 2026
Progress, Potential, And Possibilities featured an episode discussing the management of cytomegalovirus (CMV) after solid-organ transplants, including the role of Takeda Pharma's Dr. Neil Inhaber.
Published
Signal category
Research & Knowledge
Quote
“On this episode of Progress, Potential, And Possibilities, I speak with Dr. Neil Inhaber, MD, FRCPC - Head, Marketed Products and Neuroscience, Global Medical Affairs at Takeda Pharma, about:”
— Ira S. Pastor|Progress, Potential, And Possibilities team
Company
Progress, Potential, And Possibilities
Interviews with fascinating people who are creating a better tomorrow for all of us! Host, Ira Pastor
- Industry
- Broadcast Media Production and Distribution
- Location
- Philadelphia, US
- Company size
- 1 employees
Our podcast brings a constant stream of fascinating guests who are designing a better tomorrow for all of us - Host, Ira Pastor
Founded 2020